Metabolic syndrome and the risk of mild cognitive impairment and progression to dementia follow-up of the Singapore longitudinal ageing study cohort

JAMA Neurology

Volumn 73, Issue 4, 2016, Pages 456-463

  Ng, Tze Pin ^a   Feng, Liang ^a   Nyunt, Ma Shwe Zin ^a   Feng, Lei ^a   Gao, Qi ^a   Lim, May Li ^a   Collinson, Simon L ^b   Chong, Mei Sian ^c   Lim, Wee Shiong ^c   Lee, Tih Shih ^b   Yap, Philip ^a   Yap, Keng Bee ^d,e  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d KHOO TECK PUAT HOSPITAL   (Singapore)

^e ALEXANDRA HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGING; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MILD COGNITIVE IMPAIRMENT; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SINGAPORE; AGED; DISEASE COURSE; HEALTH SURVEY; MIDDLE AGED; PATHOLOGY; PROCEDURES; PSYCHOLOGY; RISK FACTOR;

AGED; AGING; COHORT STUDIES; DEMENTIA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; SINGAPORE;

EID: 84963799715     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2015.4899     Document Type: Article

References (46)

1. Grundy SM, Cleeman JI, Daniels SR, et al; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [published corrections appear in Circulation. 2005;112(17):e298 and 2005;112(17):e297]. Circulation. 2005;112(17):2735-2752.
2. Alzheimer's Disease International. World Alzheimer Report 2014: Dementia and Risk Reduction: An Analysis of Protective and Modifiable Factors. http://www.alz.co.uk/research/world-report-2014. Published September 2014. Accessed January 19, 2016.
3. Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology. 2002;58(8):1175-1181.
4. Skoog I. Highs and lows of blood pressure: a cause of Alzheimer's disease? Lancet Neurol. 2003;2(6):334.
5. Reitz C, Tang MX, Luchsinger J, Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol. 2004;61(5):705-714.
6. Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA. Change in body mass index and risk of incident Alzheimer disease. Neurology. 2005;65(6):892-897.
7. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R. Measures of adiposity and dementia risk in elderly persons. Arch Neurol. 2007;64(3):392-398.
8. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N. Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc. 2007;55(5):758-762.
9. Dik MG, Jonker C, Comijs HC, et al. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care. 2007;30(10):2655-2660.
10. Komulainen P, Lakka TA, Kivipelto M, et al. Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dement Geriatr Cogn Disord. 2007;23(1):29-34.
11. Ho RC, Niti M, Yap KB, Kua EH, Ng TP. Metabolic syndrome and cognitive decline in Chinese older adults: RESULTS: from the Singapore Longitudinal Ageing studies. Am J Geriatr Psychiatry. 2008;16(6):519-522.
12. Van Den Berg E, Biessels GJ, De Craen AJ, Gussekloo J, Westendorp RG. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology. 2007;69(10):979-985.
13. Vanhanen M, Koivisto K, Moilanen L, et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology. 2006;67(5):843-847.
14. Razay G, Vreugdenhil A, Wilcock G. The metabolic syndrome and Alzheimer disease. Arch Neurol. 2007;64(1):93-96.
15. Kalmijn S, Foley D, White L, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men: the Honolulu-Asia Aging Study. Arterioscler Thromb Vasc Biol. 2000;20(10):2255-2260.
16. Raffaitin C, Gin H, Empana JP, et al. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care. 2009;32(1):169-174.
17. Solfrizzi V, Scafato E, Capurso C, et al; Italian Longitudinal Study on Ageing Working Group. Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing. J Neurol Neurosurg Psychiatry. 2010;81(4):433-440.
18. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord. 2007;24(3):185-192.
19. Forti P, Pisacane N, Rietti E, et al. Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc. 2010;58(3):487-492.
20. Roberts RO, Geda YE, Knopman DS, et al. Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study. Alzheimer Dis Assoc Disord. 2010;24(1):11-18.
21. Feng L, Chong MS, Lim WS, et al. Metabolic syndrome and amnestic mild cognitive impairment: Singapore Longitudinal Ageing Study-2 findings. J Alzheimers Dis. 2013;34(3):649-657.
22. Yaffe K, Weston AL, Blackwell T, Krueger KA. The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol. 2009;66(3):324-328.
23. Solfrizzi V, Scafato E, Capurso C, et al; Italian Longitudinal Study on Aging Working Group. Metabolic syndrome, mild cognitive impairment, and progression to dementia. Neurobiol Aging. 2011;32(11):1932-1941.
24. Niti M, Yap KB, Kua EH, Tan CH, Ng TP. Physical, social and productive leisure activities, cognitive decline and interaction with APOE-ϵ4 genotype in Chinese older adults. Int Psychogeriatr. 2008;20(2):237-251.
25. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet. 2005;366(9491):1059-1062.
26. Ng TP, Niti M, Chiam PC, Kua EH. Ethnic and educational differences in cognitive test performance on Mini-Mental State Examination in Asians. Am J Geriatr Psychiatry. 2007;15(2):130-139.
27. Feng L, Chong MS, Lim WS, Ng TP. The Modified Mini-Mental State Examination test: normative data for Singapore Chinese older adults and its performance in detecting early cognitive impairment. Singapore Med J. 2012;53(7):458-462.
28. Rey A. L'Examen Clinique en Psychologie [Clinical Examination in Psychology]. Paris: Presses Universitaires de France; 1964.
29. Wechsler D. Wechsler Memory Scale. 3rd ed. San Antonio, TX: Psychological Corp; 1997.
30. Smith A. Symbol Digit Modality Test. Los Angeles, CA: Western Psychological Services; 1991.
31. Delis DC, Kaplan E, Kramer JH. The Delis-Kaplan Executive Function System. San Antonio, TX: Psychological Corp; 2001.
32. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. 2nd ed. South Tucson, AZ: Neuropsychology Press; 1993.
33. Wechsler D. WAIS-III Administration and Scoring Manual. San Antonio, TX: Psychological Corp; 1997.
34. Feng L, Ng TP, Chuah L, Niti M, Kua EH. Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore Longitudinal Ageing Study. Am J Clin Nutr. 2006;84(6):1506-1512.
35. Lee CK, Collinson SL, Feng L, Ng TP. Preliminary normative neuropsychological data for an elderly Chinese population. Clin Neuropsychol. 2012;26(2):321-334.
36. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183-194.
37. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment: beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240-246.
38. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-65.
39. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994.
40. Laudisio A, Marzetti E, Pagano F, et al. Association of metabolic syndrome with cognitive function: the role of sex and age. Clin Nutr. 2008;27(5):747-754.
41. Hassenstab JJ, Sweat V, Bruehl H, Convit A. Metabolic syndrome is associated with learning and recall impairment in middle age. Dement Geriatr Cogn Disord. 2010;29(4):356-362.
42. White H, Pieper C, Schmader K, Fillenbaum G. Weight change in Alzheimer's disease. J Am Geriatr Soc. 1996;44(3):265-272.
43. Luchsinger JA, Gustafson DR. Adiposity, type 2 diabetes, and Alzheimer's disease. J Alzheimers Dis. 2009;16(4):693-704.
44. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005;62(10):1556-1560.
45. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology. 2008;71(14):1057-1064.
46. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003;163(13):1524-1528.